Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF
Clinical trial NCT02387229 · TERMINATED
Trial details
- NCT number
- NCT02387229
- Sponsor
- Montreal Heart Institute
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2024-05-18
- Enrollment
- 1238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.